EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

This list contains hazardous substances for purposes of the Medical Devices Regulation (MDR), based on the legislation's Annex I general safety and performance requirements, including for chemical, physical and biological properties. Specifically, the non-exhaustive database is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list).

Last updated 01 maj 2024. Database contains 4917 unique substances/entries.

Filter the list

Visar 1 751-1 800 av 4 917 resultat.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)	EU REACH: List of SVHC	EU_BA Directive 2000/54/EC
chrysene	205-923-4	218-01-9	Carc. 1B; Muta. 2	C Carcinogenic (article 57a) PBT Persistent, Bioaccumulative and Toxic (article 57d) VPVB very Persistent and very Bioaccumulative (article 57e)		Details
chrysoidine acetate; 4-(phenylazo)benzene-1,3-diamine acetate	279-116-0	79234-33-6	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine C10-14-alkyl derivatives; benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds; with 4-(phenylazo)-1,3-benzenediamine	286-946-7	85407-90-5	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine compound with dibutylnaphthalene sulfonic acid; dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1)	304-236-8	94247-67-3	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine dihydrochloride; 4-(phenylazo)benzene-1,3-diamine dihydrochloride	281-549-5	83968-67-6	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine monoacetate; 4-(phenylazo)benzene-1,3-diamine monoacetate	278-290-5	75660-25-2	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine monohydrochloride; 4-phenylazophenylene-1,3-diamine monohydrochloride	208-545-8	532-82-1	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine sulfate; bis[4-(phenylazo)benzene-1,3-diamine] sulfate	282-432-1	84196-22-5	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine-p-dodecylbenzenesulfonate; dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1)	264-409-8	63681-54-9	Muta. 2; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1			Details
chrysoidine; 4-(phenylazo)benzene-1,3-diamine	207-803-7	495-54-5	Muta. 2; Acute Tox. 4; Skin Irrit. 2			Details
chymotrypsin	232-671-2	9004-07-3	Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1			Details
cinerin I; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(2-methylprop-1-enyl)cyclopropanecarboxylate	246-948-0	25402-06-6	Acute Tox. 4			Details
cinerin II; 3-(but-2-enyl)-2-methyl-4- oxocyclopent-2-enyl 2,2-dimethyl-3-(3-methoxy-2-methyl-3-oxoprop-1-enyl)cyclopropanecarboxylate	204-454-2	121-20-0	Acute Tox. 4			Details
cinidon ethyl (ISO); ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate	604-318-6	142891-20-1	Carc. 2; Skin Sens. 1			Details
cinmethylin (ISO); exo-(±)-1-methyl-2-(2-methylbenzyloxy)-4-isopropyl-7-oxabicyclo(2.2.1)heptane ARGOLD; CINMETHYLIN; WL 95481	402-410-9	87818-31-3	Acute Tox. 4			Details
cinnamaldehyde; 3-phenylprop-2-enal; cinnamic aldehyde; cinnamal	203-213-9	104-55-2	Skin Sens. 1A			Details
cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride	216-906-6	1694-82-2	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1			Details
cis-1,2,3,6-tetrahydrophthalicanhydride	213-308-7	935-79-5	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1			Details
cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine	425-080-8	104860-26-6	Acute Tox. 4; STOT RE 2; Eye Dam. 1			Details
cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride	426-020-3	51229-78-8	Flam. Sol. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1			Details
cis-1-(3-chloropropyl)-2,6-dimethyl-piperidin hydrochloride PD 133602-2	417-430-3	63645-17-0	Acute Tox. 3; STOT RE 2; Skin Sens. 1			Details
cis-1-amino-2,3-dihydro-1H-inden-2-ol	422-660-2	7480-35-5	Eye Dam. 1; Skin Sens. 1			Details
cis-2-methylcyclohexanol	231-187-9	7443-70-1	Acute Tox. 4			Details
cis-cyclohexane-1,2-dicarboxylicanhydride	236-086-3	13149-00-3	Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1	RSP Respiratory sensitising properties (Article 57(f)) - human health)		Details
cis-dichloroethylene	205-859-7	156-59-2	Flam. Liq. 2; Acute Tox. 4			Details
citral	226-394-6	5392-40-5	Skin Irrit. 2; Skin Sens. 1			Details
citric acid	201-069-1	77-92-9	Eye Irrit. 2; STOT SE 3			Details
citric acid, ammonium nickel salt	242-161-1	18283-82-4	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1			Details
citric acid, nickel salt	245-119-0	22605-92-1	Carc. 1A; Muta. 2; Repr. 1B; STOT RE 1; Resp. Sens. 1; Skin Sens. 1			Details
Cladophialophora bantiana	-	-			F Fungi	Details
Clarified oils (petroleum), catalytic cracked; Heavy Fuel oil [A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] A complex combination of hydrocarbons produced as the residual fraction from distillation of the products from a catalytic cracking process. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.	265-064-6	64741-62-4	Carc. 1B			Details
Clarified oils (petroleum), hydrodesulfurized catalytic cracked; Heavy Fuel oil [A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350 °C (662 °F). This stream is likely to contain 5 wt. % or more of 4-to 6-membered condensed ring aromatic hydrocarbons.] A complex combination of hydrocarbons obtained by treating catalytic cracked clarified oil with hydrogen to convert organic sulfur to hydrogen sulfide which is removed. It consists of hydrocarbons having carbon numbers predominantly greater than C20 and boiling above approximately 350°C (662°F). This stream is likely to contain 5 wt. % or more of 4- to 6-membered condensed ring aromatic hydrocarbons.	269-782-0	68333-26-6	Carc. 1B			Details
clethodim (ISO); (5RS)-2-{(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5-[(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex-2-en-1-one	619-396-7	99129-21-2	Acute Tox. 4; Skin Sens. 1			Details
clodinafop-propargyl (ISO)	600-662-6	105512-06-9	Acute Tox. 4; STOT RE 2; Skin Sens. 1			Details
clomazone (ISO); 2-(2-chlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one	617-258-0	81777-89-1	Acute Tox. 4			Details
Clonorchis sinensis	-	-			P Parasites	Details
Clonorchisviverrini	-	-			P Parasites	Details
clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid	216-935-4	1702-17-6	Eye Dam. 1			Details
clorofene; chlorophene; 2-benzyl-4-chlorophenol	204-385-8	120-32-1	Carc. 2; Repr. 2; Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Eye Dam. 1; STOT RE 2			Details
Clostridium botulinum	-	-			B Bacteria and similar species	Details
Clostridium perfringens	-	-			B Bacteria and similar species	Details
Clostridium spp.	-	-			B Bacteria and similar species	Details
Clostridium tetani	-	-			B Bacteria and similar species	Details
clothianidin (ISO); (E)-1-(2-chloro-1,3-thiazol-5-ylmethyl)-3-methyl-2-nitroguanidine	433-460-1	210880-92-5	Repr. 2; Acute Tox. 4; STOT SE 1			Details
Coal liquids, liq. solvent extn. [The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.] The substantially solvent-free product obtained by the distillation of the solvent from filtered coal extract solution produced by digesting coal in a liquid solvent. A black semi-solid, composed primarily of a complex combination of condensed-ring aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic compounds and other aromatic oxygen compounds, and their alkyl derivatives.	302-683-3	94114-48-4	Carc. 1B			Details
Coal liquids, liq. solvent extn. soln. [The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydro-genated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.] The product obtained by filtration of coal mineral matter and undissolved coal from coal extract solution produced by digesting coal in a liquid solvent. A black, viscous, highly complex liquid combination composed primarily of aromatic and partly hydrogenated aromatic hydrocarbons, aromatic nitrogen compounds, aromatic sulfur compounds, phenolic and other aromatic oxygen compounds and their alkyl derivatives.	302-682-8	94114-47-3	Carc. 1B			Details
cobalt	231-158-0	7440-48-4	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1			Details
cobalt carbonate	208-169-4	513-79-1	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt di(acetate)	200-755-8	71-48-7	Carc. 1B; Muta. 2; Repr. 1B; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details
cobalt dichloride	231-589-4	7646-79-9	Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 4; Resp. Sens. 1; Skin Sens. 1	C Carcinogenic (article 57a) R Toxic for reproduction (article 57c)		Details

Visar 1 751-1 800 av 4 917 resultat.

Export search results to:

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

EU-MEDICAL_DEVICES_REGULATION-ANX_I_SEC_10

Medical Devices Regulation - Hazardous Substances

EU. Hazardous Substances for Purposes of Medical Devices Regulation 2017/745/EU, 5 May 2017, as amended by Regulation 2020/561/EU, 24 April 2020

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 01 maj 2024. Database contains 4917 unique substances/entries.

Footer Nav Items